Gareth Morgan

A protein biochemist whose research examines why antibody light chains misfold and aggregate into amyloid fibrils in light-chain (AL) amyloidosis. His group combines biochemical experiments with computational structure prediction to understand light-chain instability and to develop small molecules that stabilize the proteins as potential therapies.